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Background: Exhaled nitric oxide has been proposed as a marker for airway inflammation in asthma.
The aim of this study was to compare exhaled nitric oxide levels with inflammatory cells and mediators
in bronchoalveolar lavage fluid from asthmatic and normal children.
Methods: Children were recruited from elective surgical lists and a non-bronchoscopic
bronchoalveolar lavage (BAL) was performed after induction of anaesthesia. Exhaled nitric oxide (parts
per billion) was measured by two techniques: tidal breathing and restricted breath.
Results: Median (interquartile range) exhaled nitric oxide measured by restricted breath was
increased in asthmatics compared with normal children (24.3 (10.5–66.5) v 9.7 (6.5–16.5),
difference between medians 14.6 (95% CI 5.1 to 29.9), p=0.001). In asthmatic children exhaled nitric
oxide correlated significantly with percentage eosinophils (r=0.78, p<0.001 (tidal breathing) and
r=0.78, p<0.001 (restricted breath)) and with eosinophilic cationic protein (r=0.53, p<0.01 (restricted
breath)), but not with other inflammatory cells in the BAL fluid. The area under the receiver operator
characteristic curves for the prediction of the presence of eosinophilic airways inflammation by exhaled
nitric oxide (tidal and restricted) was 0.80 and 0.87, respectively.
Conclusions: Exhaled nitric oxide correlates closely with percentage eosinophils in BAL fluid in asth-
matic children and is therefore likely to be a useful non-invasive marker of airway inflammation.
Exhaled nitric oxide (eNO) is known to be increased inboth adult and childhood asthma.1–4 Patients with acuteasthma have high levels of eNO which decrease with oral
corticosteroid treatment.5 Inhaled corticosteroids are known
to reduce eNO levels in asthmatic subjects not previously
treated with them,6 7 and recently a leukotriene receptor
antagonist has been shown to reduce eNO levels in asthmatic
children.8 9 Several, but not all, studies have shown negative
correlations between eNO levels and PC20 methacholine/
histamine,10–13 and forced expiratory volume in 1 second
(FEV1).
4 7 11 12 14 15 There is a correlation between eNO and the
percentage of eosinophils in induced sputum from both
adults10 12 and children16 17 with asthma, but the relationship
between eNO levels and the percentage of eosinophils in
bronchoalveolar lavage (BAL) fluid in children has not been
reported. This study examines direct measures of airway
inflammation in BAL fluid with eNO concentrations in
children.
METHODS
Participants
Seventy one children (29 atopic asthmatics, 15 atopic normal
controls, and 27 non-atopic normal controls) attending the
Royal Belfast Hospital for Sick Children for elective surgical
procedures were recruited. BAL was performed using a
non-bronchoscopic technique immediately after induction of
anaesthesia, as described previously.18 19 Parental written
informed consent was obtained and the study was approved
by the research ethics committee.
Exhaled nitric oxide measurement
Exhaled NO was measured online by both restricted breath
analysis and the tidal breathing technique according to the
recommendations of the American Thoracic Society20 using a
chemiluminescence analyser (NOA 280, Sievers Instruments
Inc) with a sensitivity of 0.5 parts per billion (ppb), a detection
range of 0.5–500 000 ppb, and a response time of 200 ms.
Briefly, for the restricted breath technique the subject was
instructed to inhale through the mouth to total lung capacity
and immediately exhale through the mouthpiece against a
fixed resistance. Maintenance of a constant flow was achieved
using a visual analogue feedback on the computer screen. A
flow rate of 50 ml/s was used which corresponded to a mouth
pressure of 17 cm H2O. An exhalation of at least 6 seconds
with a plateau of at least 2 seconds duration was required to
calculate the NO plateau. The tidal breathing technique was
an online breath by breath analysis and the mean NO plateau
was calculated from at least five breaths. If the ambient NO
level was greater than 20 ppb, subjects inspired room air
through a nitric oxide scrubber.
Subject classification
A detailed respiratory/atopy questionnaire was administered
to parents of all children.19 Subjects were classified as
asthmatic if they had a history of wheezing on different occa-
sions (precipitated by respiratory infection, exercise, or expo-
sure to allergens) and if a physician or general practitioner had
diagnosed them with asthma. All children were assessed by
the anaesthetist and were deemed sufficiently stable to
undergo a general anaesthetic. Details of asthma medication
and medication compliance were also obtained. Atopy was
defined as in previous publications18 19 as either a personal his-
tory of atopic disease or two first degree relatives with atopic
disease or a raised total IgE. All subjects were free of current
respiratory infection.
Bronchoalveolar lavage and assessment of airway
inflammation
BAL fluid was centrifuged (200g, 5 min, 4°C) and cytospin
preparations produced by a modification of the coverslip
method.19 Cells were stained with Diff-Quik for differential cell
counting (minimum of 1000 cells) or toluidine blue for mast
cell counting (3000–5000 cells).18 Supernatants from the BAL
fluid were stored at –70°C until measurement of eosinophil
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cationic protein (ECP) or histamine using commercially avail-
able radioimmunoassays (Pharmacia Upjohn Diagnostics and
Immunotech, respectively). Total serum IgE was measured
using a commercially available radioimmunoassay (Pharma-
cia Upjohn Diagnostics). The percentage of blood eosinophils
was also quantified.
Analysis of data
All values are quoted as median and interquartile range (IQR).
Spearman’s correlation was used to compare inflammatory
cells and mediators with eNO. The Mann-Whitney U test
(Hodges-Lehmann difference between medians) and the
Kruskal-Wallis test (with multiple comparisons adjustment)
were used to compare eNO levels between subgroups. Receiver
operating characteristic curves were generated to investigate
the sensitivity, specificity, and positive likelihood ratio of eNO
and blood eosinophils to predict the presence of raised
eosinophils in the BAL fluid (>0.86%, our upper normal refer-
ence limit18). Statistical analyses were performed using
Unistat 5 (Unistat Ltd, London, UK).
RESULTS
Twenty nine children with atopic asthma, 15 atopic normal
control children, and 27 non-atopic normal children under-
went both BAL and measurement of eNO levels. The median
ambient level pf NO was 4.0 ppb (range 0.3–43.0). Demo-
graphic data, eNO values, and percentage BAL fluid eosi-
nophils for the three groups are shown in table 1. Nine asth-
matic subjects were taking inhaled corticosteroids and all had
been on this treatment for at least 3 months. Eight children
were treated with 200–800 µg/day inhaled corticosteroids
(budesonide, n=5; beclomethasone, n=2; fluticasone, n=1).
One child was taking nebulised budesonide at a dose up to
4 mg/day.
Exhaled NO levels
Median (IQR) eNO values (ppb) for the combined non-
asthmatic control subjects (atopic and non-atopic) were 6.0
(3.6–8.9) using the tidal breathing method and 9.7 (6.5–16.5)
with the restricted breath technique. The levels of eNO were
significantly higher in asthmatic than in non-asthmatic
children using both the tidal breathing method (difference
between medians 3.4 ppb (95% CI 0.9 to 6.8), p=0.01) and
restricted breath analysis (difference between medians
14.6 ppb (95% CI 5.1 to 29.9), p=0.001).
When the non-asthmatic control group was divided into
atopic and non-atopic controls, there was no difference
between the subgroups in median eNO levels measured by the
tidal breathing method. However, the non-atopic controls had
significantly lower levels than the asthmatic group (difference
between medians 2.8 (95% CI 0.8 to 7.8), p=0.01, fig 1A). With
the restricted breath method there was also no difference
between atopic and non-atopic non-asthmatic controls but
again there was a statistically significant difference between
non-atopic controls and the asthmatic children (difference
between medians 14.8 (95% CI 5.7 to 34.2), p<0.001, fig 1B).
Table 1 Baseline demographic characteristics, eNO values, and percentage BAL
fluid eosinophils in the three groups (n=71)
Parameter
Subjects with
asthma (n=29)
Non-atopic control
subjects (n=27)
Atopic control
subjects (n=15)
Median (IQR) age (years) 9.4 (7.2–11.3) 9.0 (7.3–10.8) 9.3 (7.1–10.4)
Sex, M (%) 18 (62) 17 (63) 11 (73)
Using ICS, n (%) 9 (31) 0 (0) 0 (0)
Tidal eNO (ppb)
Median (IQR) 9.6 (5.6–19.2) 6.8 (3.5–8.2) 5.8 (4.0–12.5)
Range 0.9–37.6 0–18.0 2.1–28.0
Restricted eNO (ppb)
Median (IQR) 24.3 (10.5–66.5) 9.5 (4.9–13.6) 11.9 (9.1–23.2)
Range 2.5–267 0.1–23.0 6.6–34.6
BAL eosinophil (%)
Median (IQR) 1.5 (0.4–4.1) 0.2 (0.1–0.3) 0.3 (0.1–3.9)
Range 0–36.3 0–1.9 0–6.2
ICS = inhaled corticosteroids; eNO = exhaled nitric oxide; IQR = interquartile range; BAL = bronchoalveolar
lavage.
Figure 1 Exhaled NO levels in asthmatic patients, non-atopic controls, and atopic controls measured by (A) the tidal breathing method and
(B) restricted breath analysis. Horizontal bars represent median values (Mann-Whitney U test).
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When eNO levels (measured by the tidal breathing method
or by restricted breath analysis) and percentage BAL fluid
eosinophils in the asthmatic subjects were analysed according
to whether or not the subject was receiving inhaled
corticosteroids, no significant differences were found (data
not shown).
Correlation analyses
The levels of eNO correlated with percentage eosinophils in
BAL fluid using both the tidal breathing technique (r=0.78,
p<0.001, fig 2A) and restricted breath analysis (r=0.78,
p<0.001, fig 2B) in asthmatic children but not in non-
asthmatic controls (tidal breathing: r=–0.01, p=0.99; re-
stricted breath: r=0.28, p=0.13). In the subgroup of asthmat-
ics taking inhaled corticosteroids, the correlation between
percentage BAL eosinophils and eNO remained (tidal breath-
ing: r=0.78, p=0.01; restricted breath: r=0.78, p=0.04) and
was similar to that found in the steroid naïve asthmatic
patients (tidal breathing: r=0.79, p<0.001; restricted breath:
r=0.84, p<0.001). Exhaled NO levels did not correlate with
percentage mast cells in asthmatic patients measured by tidal
breathing (r=–0.18, p=0.52) or restricted breath analysis
(r=0.08, p=0.79), nor did it correlate with any other cell type
found in BAL fluid (data not shown). ECP was not detectable
in BAL fluid from atopic control children, in 26 of 27
non-atopic control children (1.9 µg/l (1.9–1.9)) and 19 of 29
asthmatic children (1.9 µg/l (1.9–2.4)). Despite this, there was
a significant positive correlation in asthmatic children
between eNO levels and BAL fluid levels of ECP (tidal breath-
ing: r=0.52, p=0.004; restricted breath: r=0.53, p=0.007).
Furthermore, in asthmatic children there was a weak but
non-significant correlation (tidal breathing: r=0.4, p=0.09;
restricted breath: r=0.4, p=0.09) with blood eosinophil count
(4.2% (2.6–7.9)). BAL fluid histamine concentrations in asth-
matic children (3.3 nM (0.2–17.1)) correlated poorly with
eNO levels (tidal breathing: r=0.25, p=0.31, restricted breath:
r=0.35, p=0.19).
Receiver operating characteristic (ROC) curves
A BAL eosinophil value of 0.86% was defined as the cut off
value for defining the presence or absence of eosinophilic air-
ways inflammation as this value has been shown previously to
be the upper 95% confidence interval for the 95th percentile in
normal children.18 The ROC curves using eNO levels
(measured by tidal breathing and restricted breath analysis)
to predict airways inflammation are shown in fig 3. The area
under the curve (AUC) and the best sensitivity, specificity, and
positive likelihood ratio with corresponding cut off values for
eNO levels and blood eosinophil count are shown in table 2.
There was no significant difference in the AUC when eNO lev-
els (measured by tidal breathing or restricted breath analysis)
or blood eosinophil percentage were used to predict the pres-
ence of eosinophilic airways inflammation.
Figure 2 Spearman’s correlations (r) between exhaled NO levels of asthmatic subjects measured by (A) tidal breathing and (B) restricted
breath analysis and percentage BAL fluid eosinophils.
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Figure 3 Receiver operating characteristic curve for the presence
of airways inflammation. Heavy line represents eNO levels
measured by restricted breath analysis (area under curve
(AUC)=0.87), lighter line represents eNO levels measured by tidal
breathing (AUC=0.80); diagonal line is chance predictor
(AUC=0.5).
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Table 2 Comparison of the sensitivity, specificity, and likelihood ratio of a positive
test for the prediction of airways inflammation with the corresponding cut off values
for eNO (measured by tidal breathing (TB) or restricted breath analysis (RB)) and
blood eosinophil count
AUC (SE)
Cut off
value
Sensitivity
(%)
Specificity
(%)
Positive
likelihood ratio
eNO (TB) 0.80 (0.07) 8.9 ppb 76 83 4.5
eNO (RB) 0.87 (0.05) 16.9 ppb 81 80 4.1
Blood eosinophils 0.74 (0.1) 5.6% 69 87 5.3
AUC = area under curve; eNO = exhaled nitric oxide; TB = tidal breathing; RB = restricted breath.
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DISCUSSION
Two different techniques were used to measure eNO levels in
children and compared with inflammatory markers in BAL
fluid. Restricted breath analysis could be successfully per-
formed in children as young as 4 years and the tidal breathing
technique was performed by children as young as 3 years.
However, the former technique is likely to give more reliable
results because it is less subject to the influence of nasal NO.21
The actual eNO values obtained in this study by restricted
breath analysis are somewhat higher than in other published
studies in children.16 17 The discrepancy may relate to the
different flows generated at the mouth in each study. Plateau
levels of eNO are known to increase with decreasing flow at
the mouth.21 In our study the pressure at the mouth was
17 cm H2O and the flow was comparatively low at 50 ml/s,
whereas other studies have used lower mouth pressures, typi-
cally 5 cm H2O, and higher flows.
16 17
We have confirmed that asthmatic children have increased
eNO levels compared with normal children, which is in keep-
ing with other studies.3 4 Asthmatic children had significantly
higher eNO levels than non-atopic non-asthmatic controls.
Atopic non-asthmatic controls had intermediate eNO levels
but there were no statistically significant differences in eNO
levels between this group and either the non-atopic controls or
asthmatics. There has been some debate as to whether atopy is
an independent factor for increased eNO levels in non-
asthmatic subjects. One large study of 157 children22 showed
that eNO increased in relation to the number of positive skin
prick reactions, but another study showed no difference in
eNO levels between atopic and non-atopic normal children.23
Our study may lend support to the former, although the num-
bers in our subgroups are relatively small. One potential defi-
ciency in our study is the absence of skin prick test data to help
define atopy, but instead we classified children as atopic based
on a personal and/or strong family history of atopy and total
serum IgE concentrations. Only four children were classified
as “atopic” based solely on having two atopic parents.
Exclusion of these patients would not alter our results.
This study shows that, in asthmatic children but not in con-
trols, eNO levels and BAL fluid eosinophil percentages
correlate well regardless of the methods used to measure eNO.
In contrast, no correlations were found between eNO levels
and other inflammatory cells, particularly mast cells which are
increased in the airways of asthmatic children.19 These
findings are consistent with other studies comparing eNO
with markers of airway inflammation in induced sputum both
in adults and children.10 12 16 17 The value of eNO as a marker of
eosinophilic inflammation in corticosteroid treated asthmatic
subjects has been questioned as some unstable asthmatics
treated with corticosteroids have normal eNO levels.12 In our
study eNO levels correlated with percentage eosinophils in
BAL fluid even in the corticosteroid treated group. The corre-
lation in the corticosteroid treated subgroup was similar to
that for the steroid naïve asthmatics and suggests that eNO
may be a useful marker even in steroid treated asthmatics.
This result is consistent with the study of Mattes et al who
found a correlation between inflammatory markers in
induced sputum and eNO levels in corticosteroid treated asth-
matic children.16 By contrast, Piacentini et al found no correla-
tion between eNO levels and sputum inflammatory markers in
their corticosteroid treated asthmatic subjects.17 This discrep-
ancy could be explained by the small numbers studied and the
differences in clinical characteristics of the corticosteroid
treated asthmatic subjects between studies. Although eNO
levels and BAL histamine concentrations did not correlate, a
significant correlation was found between eNO and ECP in
BAL fluid in the asthmatic children. This is in agreement with
the study by Mattes et al which showed a correlation between
eNO and ECP levels (both serum and sputum)16 but contrasts
with the findings of Piacentini et al.17 In the latter study the
authors admit that the lack of correlation with sputum ECP
levels is difficult to explain given the correlation with sputum
eosinophils. The small numbers in their subgroups (10 steroid
treated, 15 steroid naïve) may account for the lack of
significant difference. Thus, as we have shown, eNO may not
only serve as a non-invasive marker of airway eosinophil per-
centages but also as a marker of eosinophil activation within
the airways.
The data obtained from plotting the ROC curves allow the
clinical value of eNO as a non-invasive predictor of airways
inflammation to be assessed and compared against blood
eosinophil count. A cut off eNO value of 17 ppb measured by
restricted breath analysis resulted in a sensitivity and specifi-
city of 81% and 80%, respectively. Similar sensitivity and spe-
cificity results were obtained using a cut off eNO value of
9 ppb measured by tidal breathing. These results compare
favourably with the results obtained with the blood eosinophil
count. Similar results were obtained in a previous study in
which blood eosinophils were examined as a non-invasive
marker of airway inflammation.24 While no significant differ-
ence was seen when comparing the area under the curve for
eNO levels and blood eosinophil count, we believe that eNO
has advantages over the blood eosinophil count as it is
minimally invasive and provides an immediate result which
can be interpreted in a clinical context with the patient
present.
In conclusion, we have shown that eNO measurement is a
useful method of indirectly assessing eosinophilic airway
inflammation in asthmatic children, whether or not they are
taking inhaled corticosteroids at the time of measurement. It
may also be a useful adjunct for diagnosing asthma (as recur-
rent wheezing plus eosinophilic airways inflammation),
particularly in younger children where it is often difficult to
get other objective measures of asthma.
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